mTOR, la cible fonctionnelle de la rapamycine
Med Sci (Paris), 26 12 (2010) 1056-1060
Published online: 2010-12-15
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Regulation of Autophagy Signaling Pathways by Ginseng Saponins: A Review
Zhu‐Jun Zhuang, Fa‐Jing Li, Di Lv, Heng‐Qian Duan, Lin‐Yi Chen, Peng Chen, Zhi‐Qiang Shen and Bo HeChemistry & Biodiversity 21 (8) (2024)
https://doi.org/10.1002/cbdv.202400934
Research progress on aging mechanism and drugs and the role of stem cells in anti-aging process
Yuxuan Zhang, Qingjuan Li, Yuhu Niu, Kaixin Wei, Xiuwei Wang, Bo Niu and Li ZhangExperimental Gerontology 179 112248 (2023)
https://doi.org/10.1016/j.exger.2023.112248
Recent advances of the mammalian target of rapamycin signaling in mesenchymal stem cells
Huarui Cai, Zhongze Wang, Wenhan Tang, Xiaoxue Ke and Erhu ZhaoFrontiers in Genetics 13 (2022)
https://doi.org/10.3389/fgene.2022.970699
Les métabokines, des médiateurs essentiels de l’immunité anti-infectieuse
Adeline Cezard, Sarah Monard, Déborah Bréa-Diakite, Antoine Guillon and Mustapha Si-Taharmédecine/sciences 37 (4) 342 (2021)
https://doi.org/10.1051/medsci/2021031
mTOR signalling: jack-of-all-trades
Yassine El Hiani, Emmanuel Eroume-A Egom and Xian-Ping DongBiochemistry and Cell Biology 97 (1) 58 (2019)
https://doi.org/10.1139/bcb-2018-0004
La rapamycine ouvre l’ère des thérapies ciblées dans les malformations veineuses
Emmanuel Seront, Nisha Limaye, Laurence M. Boon and Miikka Vikkulamédecine/sciences 32 (6-7) 574 (2016)
https://doi.org/10.1051/medsci/20163206016
Identification par deux criblages simultanés indépendants d’une famille d’inhibiteurs du métabolisme des glycérolipides
Florian Chevalier and Éric Maréchalmédecine/sciences 31 (3) 320 (2015)
https://doi.org/10.1051/medsci/20153103018
Les nouvelles promesses de la metformine
Marc Foretz and Benoit Violletmédecine/sciences 30 (1) 82 (2014)
https://doi.org/10.1051/medsci/20143001018
Rôle clé de la kinase eEF2K dans la survie cellulaire à la privation de nutriments
Gabriel Leprivier, Barak Rotblat, Olivier Delattre and Poul H. Sorensenmédecine/sciences 29 (11) 951 (2013)
https://doi.org/10.1051/medsci/20132911007
mTORC1 et sirolimus
Pauline Tartarin and Pascal Fromentmédecine/sciences 29 (2) 200 (2013)
https://doi.org/10.1051/medsci/2013292019
Targeting the Cellular Signaling: BRAF Inhibition and Beyond for the Treatment of Metastatic Malignant Melanoma
Felipe Ades and Otto Metzger-FilhoDermatology Research and Practice 2012 1 (2012)
https://doi.org/10.1155/2012/259170
« Se manger soi-même » pour survivre
Benoit Viollet and Marc Foretzmédecine/sciences 27 (6-7) 569 (2011)
https://doi.org/10.1051/medsci/2011276002
Arginine et réponse immunitaire innée
Virginie Mieulet and Richard F. Lambmédecine/sciences 27 (5) 461 (2011)
https://doi.org/10.1051/medsci/2011275005